Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 62.20
-0.10 (-0.16%)
Jul 24, 2026, 5:29 PM CET
Devyser Diagnostics AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 250.4 | 250.5 | 216.9 | 169.3 | 126.6 | 93.48 | |
Revenue Growth (YoY) | 6.51% | 15.49% | 28.12% | 33.73% | 35.43% | 42.31% |
Cost of Revenue | 54.6 | 48.6 | 44.2 | 24.5 | 23.2 | 21.57 |
Gross Profit | 195.8 | 201.9 | 172.7 | 144.7 | 103.4 | 71.91 |
Selling, General & Admin | 156 | 173.3 | 193.1 | 163.5 | 132.1 | 75.65 |
Research & Development | 17.6 | 18 | 43.1 | 37.8 | 26.3 | 18.07 |
Other Operating Expenses | -0.1 | 0.6 | -1.3 | 2.4 | -3 | -0.59 |
Total Operating Expenses | 173.5 | 191.9 | 234.9 | 203.7 | 155.4 | 93.13 |
Operating Income | 22.3 | 10 | -62.2 | -59 | -52 | -21.22 |
Interest Income | 4.4 | 0.9 | 8.2 | 5.3 | 0.4 | 0.26 |
Interest Expense | -4.7 | -13.6 | -3.5 | -0.8 | -1.2 | -0.95 |
Total Non-Operating Income (Expense) | -0.3 | -12.7 | 4.7 | 4.5 | -0.8 | -0.69 |
Pretax Income | 22.2 | -2.6 | -57.6 | -54.4 | -52.7 | -21.91 |
Provision for Income Taxes | 6.9 | 5.8 | 3.9 | -0.8 | -6.8 | -1.18 |
Net Income | 15.3 | -8.4 | -61.5 | -53.6 | -45.9 | -20.73 |
Net Income to Common | 15.3 | -8.4 | -61.5 | -53.6 | -46 | -20.73 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 17 | 17 | 16 | 16 | 16 | 11 |
Shares Outstanding (Diluted) | 17 | 17 | 16 | 17 | 17 | 12 |
Shares Change (YoY) | 0.69% | 1.34% | -3.57% | 2.04% | 39.90% | 27.00% |
EPS (Basic) | 0.92 | -0.51 | -3.75 | -3.31 | -2.89 | -1.85 |
EPS (Diluted) | 0.92 | -0.51 | -3.75 | -3.31 | -2.89 | -1.85 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | 34 | 8.2 | -50.7 | -81.2 | -48.4 | -18.68 |
Free Cash Flow Growth | 265.59% | - | - | - | - | - |
Free Cash Flow Per Share | 2.04 | 0.49 | -3.08 | -4.76 | -2.90 | -1.56 |
Gross Margin | 78.19% | 80.60% | 79.62% | 85.47% | 81.67% | 76.93% |
Operating Margin | 8.91% | 3.99% | -28.68% | -34.85% | -41.07% | -22.70% |
Profit Margin | 6.11% | -3.35% | -28.35% | -31.66% | -36.26% | -22.17% |
FCF Margin | 13.58% | 3.27% | -23.37% | -47.96% | -38.23% | -19.98% |
EBITDA | 51.1 | 37.1 | -34.5 | -45.9 | -43.5 | -15.19 |
EBITDA Margin | 20.41% | 14.81% | -15.91% | -27.11% | -34.36% | -16.25% |
EBIT | 22.3 | 10 | -62.2 | -59 | -52 | -21.22 |
EBIT Margin | 8.91% | 3.99% | -28.68% | -34.85% | -41.07% | -22.70% |
Effective Tax Rate | 31.08% | -223.08% | -6.77% | 1.47% | 12.90% | 5.39% |